Results 211 to 220 of about 172,514 (308)
Workflow for discovering parasitological and molecular changes related to Schistosoma mansoni infection. ABSTRACT Parasites can induce changes in their hosts, favoring the success of the infection and its development at each stage of their life cycle.
Sheila de Andrade Penteado Corrêa +12 more
wiley +1 more source
Revisiting the Role of Surgery in Non-cirrhotic Portal Hypertension: An Ambispective Observational Study in a Tertiary Care Centre. [PDF]
Girish A +3 more
europepmc +1 more source
ABSTRACT Background Patients with solid tumours or lymphomas have an increased risk of thromboembolism (TE) and thrombocytopenia. Evidence‐based strategies for anticoagulation therapy (ACT) for patients with thrombocytopenia are limited. We examined the impact of thrombocytopenia on ACT administration and bleeding incidence in children with solid ...
Andrés Felipe Fajardo +5 more
wiley +1 more source
Diffuse hepatic artery dilation: an uncommon manifestation of early cirrhosis. [PDF]
Hoang VT +3 more
europepmc +1 more source
Choroid plexus alterations in long COVID and their associations with Alzheimer's disease risks
Abstract INTRODUCTION Choroid plexus (ChP) enlargement is a neuroimaging biomarker of neuroinflammation and neurodegeneration. However, evidence of ChP structural and perfusion alterations in long coronavirus disease (COVID) and their clinical relevance remains limited.
Huize Pang +11 more
wiley +1 more source
Shunt Surgery for Pediatric Prehepatic Portal Hypertension: A Single-Center Case Series. [PDF]
Pikturnaitė G +9 more
europepmc +1 more source
Introduction Bevacizumab, a vascular endothelial growth factor inhibitor, is used off‐label for treatment of severe anaemia related to epistaxis, gastrointestinal bleeding and/or severe hepatic arteriovenous malformations (HAVM) and right‐sided cardiac failure in patients with hereditary haemorrhagic telangiectasia (HHT).
Pernille D. Haahr +18 more
wiley +1 more source
ABSTRACT Objectives Progression of hepatocellular carcinoma (HCC) and cardiovascular thrombosis (CVT) has a bidirectional causal relationship. CVT complications will increase in patients with HCC due to etiology shift from viral hepatitis to metabolic dysfunction‐related steatohepatitis.
Koji Fujita +7 more
wiley +1 more source

